You state - “Three expert advisors contributed to the development of this document, all have used the technology and 1 no longer uses it as they believed the technology did not result in improved patient outcomes.“ For clarity, so are two still using this technology?
An alternate viewpoint: Below are some opinions from the Director of the Burn Centre where RECELL is in use. I would also say an expert in the field.
Dr. Rae: Director at The Temple Burn Centre has been the leading regional burn centre for 20 years.
Dr. Lisa Rae is nationally respected in burn surgery and trauma and critical care.
She and her team are now using a new spray-on skin cell technology — known as the RECELL® System
She states: “New advancements like this spray-on skin technology really do put us at the forefront of best practices”.
Q&A WITH DR. LISA RAE How does traditional skin grafting heal severe burn victims? Dr. Rae: Patients with second- and third-degree burns generally must undergo a surgical procedure.We remove the burned skin and underlying tissue, and replace it with a thin layer of healthy donor skin taken elsewhere from their own body. This skin-grafting approach is generally very effective at healing, but it can be painful. It also can leave scarring and discoloration.
Dr. Rae: Yes, the FDA approved treatment option called the RECELL Autologous Cell Harvesting Device (RECELL System).
It requires less donor skin to achieve healing of burn wounds in less time. Temple is one of only a few hospitals that offers it. We believe this new technology can have a profound impact on our patients’ recovery, including reducing pain and scarring, improved joint mobility, faster healing and an improved long-term cosmetic result compared to traditional skin grafting.
Dr. Rae: The main advantages are faster healing, less pain, less chance of infection and decreased scarring — which improves joint mobility. Patients get out of the hospital faster, and the cosmetic results are impressive. And we can take skin from a much smaller and thinner donor site, which is especially important for patients who need a larger amount of healthy skin for grafting.
Significantly improved outcomes for unfortunate patients. What do you think?
With all new innovative technologies some time is required for acceptance. But as we know, once the acceptance phase occurs there is typically a sharp inflection with the SP. Exciting prospect for LTH. All IMO of course.
AVH Price at posting:
$6.49 Sentiment: Hold Disclosure: Held
(20min delay)
